PETALING JAYA, Malaysia, June 16, 2023 /PRNewswire/ — European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (on behalf of Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine ( Foshan) Co.) and NCL Solutions Sdn Bhd on April 15, 2023 at One world hotel.
EW Group represented by Chairman Professor Dato’ Sri Dr. Mike Chan and HK VJM Ltd was represented by Guo Liang while NCL Solutions Sdn Bhd was represented by Madame Cindy Chong Seau Joon.
EW Group will offer its insights and expertise in the research, development, formulation and production of nutraceuticals, cosmeceuticals, skin care, and therapeutics, while Sinopharm will leverage its global reach and distribution network to help EW Group reach greater heights on the world stage. More than 1,000 SKUs of EW Group’s proprietary products will be sold and distributed under Sinopharm.
The partnership will include the development of co-branded products and the creation of world-class health centers, which will be equipped with state-of-the-art technology and staffed with highly trained health professionals. Through this collaboration, both parties aim to bring world-class healthcare products and services to a broader audience and provide accessible, affordable and innovative healthcare solutions to people around the world.
Sinopharm is one of the largest healthcare groups in China, with more than 128,000 employees, 1,100 subsidiaries, and a complete industry chain covering a variety of departments. The group’s production lines are approved by the US FDA and EU authorities and pre-qualified by the WHO, gaining substantial recognition during the coronavirus pandemic for its development and distribution of the Sinopharm vaccine.
This partnership will allow EW Group to enter the China market and its revenues. By collaborating with local experts, EW Group is able to gain insight into the local market and customize its product to meet the specific needs and preferences of Chinese consumers. The signing marks a significant milestone for EW Group’s business in the China market and presents growth opportunities for the company in the consumer and wellness business.
With this collaboration, both parties will unite two giants of the healthcare industry to offer world-class healthcare products and services to people around the world. The collaboration will improve the availability of alternative medical treatments, develop new products and transfer knowledge and skills to millions of people.
European Wellness Biomedical Group
An award-winning European group, best known for its pioneering developments in organ-specific precursor (progenitor) stem cell therapies, biologic and synthetic peptides, biologic regenerative medicine, immunotherapies, and nutraceuticals and cosmeceuticals.
EW Group’s multinational business divisions include research and development, biomanufacturing, biomedical academies, hospitals and wellness centers, and distribution of nutraceutical products in 80 countries around the world. EW Group also owns and operates a growing network of internationally accredited hospitals and medical centers specializing in regenerative biomedicine and luxury wellness centers around the world. EW Group is headquartered in Germany and Malaysia (Asia Pacific) with research in Germany, Switzerland, the Czech Republic and the UK.
CONTACTO: Ferellica Anne Martin, media@european-wellness.com
Logo – https://mma.prnewswire.com/media/2010114…
View original content: https://www.prnewswire.com/news-releases/ew-group-firma-con-sinopharm-la-mayor-empresa-de-atencion-medica-de-china-301852731.html
